about
Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish CaucasiansA meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hipMeta-analysis of association between the ASPN D-repeat and osteoarthritisA genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study.Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study.Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilageNew sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association studyCommon genetic variation in the Estrogen Receptor Beta (ESR2) gene and osteoarthritis: results of a meta-analysis.Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patientsLack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus.Association of systemic lupus erythematosus clinical features with European population genetic substructure.Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only studyOverexpression of the Cytokine BAFF and Autoimmunity RiskEpigenetic regulation during fetal femur development: DNA methylation matters.Ultrasonographic assessment of enthesitis in HLA-B27 positive patients with rheumatoid arthritis, a matched case-only study.Genetic variation including nonsynonymous polymorphisms of a major aggrecanase, ADAMTS-5, in susceptibility to osteoarthritis.Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study.Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis.A broad analysis of IL1 polymorphism and rheumatoid arthritis.Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand.Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium.Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis.Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study.Association of a BMP5 microsatellite with knee osteoarthritis: case-control studyAnalysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility.Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis.Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes.Identification of three new cis-regulatory IRF5 polymorphisms: in vitro studies.Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis.Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis.Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis.Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia.Specific association of HLA-DRB1*03 with anti-carbamylated protein antibodies in patients with RAVariants Within STAT Genes Reveal Association with Anticitrullinated Protein Antibody-negative Rheumatoid Arthritis in 2 European Populations
P50
Q21195662-8F35AA30-8248-4750-8287-1022C530A589Q26995717-C0C97069-9FB7-4637-BFEB-4B8EFD90829DQ28211169-933ABD13-8937-43A8-A25C-64A13F64E2DAQ28943430-FB42E9CD-CD65-4EFC-AF35-3D9BD0FB766BQ29417079-406EF528-965E-4A3B-AA80-10B0DDE00310Q30488972-22B2CAF8-F17C-469A-A83E-11AFD1E41E1AQ30494937-5AC6D59D-BC1C-4617-884B-F5951BB83BDCQ33316881-200B0767-5BB5-4522-8ECC-EA40B2B10251Q33543752-D5CD6D10-FCCB-4CE7-AE72-807E4702D36BQ33748213-202AD4E6-F5C9-43A4-9E4B-CB5CF20D81BCQ33865776-0620C63C-0C7A-4D66-A5DA-AB1F2435416DQ33892741-93FD89F6-2861-44D3-8B6F-6987018DD47AQ34110676-EE2252A8-E890-48FE-9ADE-C48A21176EBDQ34438072-B5CFB545-C015-4800-98CA-74E5D52F56A0Q34555873-FCC36B64-B850-436B-865C-941B49150A65Q34575845-B630DED7-9635-4838-8ACB-58E627468996Q34625960-3FC58A6E-27E2-4E49-BD85-13AB7D14DDACQ34743995-E2EE815E-B764-4C77-85C5-BC0BB9F11FD7Q34758881-21305A28-3689-4C32-A110-B398BE704729Q34773968-B1CD380B-C41A-4BFF-AD06-24D3E054F028Q34788695-4EB2594F-C62C-4BD8-A031-3B450D4B8B67Q35547835-2CEAE33D-5C79-437B-A2E8-5923BAD6BF57Q35608079-707398CB-F622-456E-A86D-491077CD3DD4Q35953490-9B3E7468-FB0A-4757-B861-B746EDF49A39Q36245885-FC928C1D-624C-4B2F-99BE-B94CE7D7CBD3Q36907726-8D1A01EC-9606-470F-A673-0C17155A6B47Q37206928-F727982F-8DE6-4BA6-A803-5EA73F260726Q37608884-CB838BC4-4E6A-43BE-9568-D290A87E3380Q37609036-6BB4D0C0-BE0A-4F15-81B6-78E163C19565Q38650325-45290738-0957-4022-9B2F-2AFD206BE94DQ41697121-454AA2A0-F4AC-49D8-AEF0-7A749A24B0DDQ42632049-73957326-11B3-4042-9CCF-B64273EA487DQ48198050-84123E3F-F079-4F64-9E11-D88E9BCA3AC8Q52665701-A6D22259-015D-4183-A074-B6F954FC6D08Q53819679-DDA8F27E-B504-47B1-9269-BA5640D0B57EQ53820042-1FEA3C27-4D67-4F4E-9F20-FC7D30BE5C1AQ54322925-A3666AAB-A0A9-49CE-8158-B24FEF8130A4Q55481331-0195B1D2-BD38-47DD-9D44-DA14E187C137Q57052188-A8F257AA-2D91-4936-9E08-5A023390F161Q57224309-D6878F04-581C-4884-A0FD-41EFCC70A907
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Gonzalez
@ast
Antonio Gonzalez
@en
Antonio Gonzalez
@es
Antonio Gonzalez
@nl
Antonio Gonzalez
@sl
type
label
Antonio Gonzalez
@ast
Antonio Gonzalez
@en
Antonio Gonzalez
@es
Antonio Gonzalez
@nl
Antonio Gonzalez
@sl
prefLabel
Antonio Gonzalez
@ast
Antonio Gonzalez
@en
Antonio Gonzalez
@es
Antonio Gonzalez
@nl
Antonio Gonzalez
@sl
P106
P21
P31
P496
0000-0002-2624-0606